Dr. Wallace Akerley presently the Chairman of the Protocol Review and Monitoring system at the Huntsman Cancer Institute
(HCI), Director of the Lung Cancer Disease Center of Excellence at HCI and member of the NCCN’s Steering
Committee, Small Cell Lung Cancer Panel and NSCLC Panel.
As a medical oncologist, he has been active in clinical research for greater than 30 years with extensive
experience as a principal investigator on numerous clinical research trials. Positions held during his tenure at
Huntsman Cancer Institute include Senior Director of Community Oncology Research; Senior Director of
Clinical Research; Medical Director, Clinical Trials Office; Director, Utah Cancer Registry; and Professor of
Medicine in the Department of Hematology/Oncology at the University of Utah School of Medicine.